Peppermint oil for the treatment of irritable bowel syndrome: A systematic review and meta-analysis

Journal of Clinical Gastroenterology

Volumn 48, Issue 6, 2014, Pages 505-512

  Khanna, Reena ^a   Macdonald, John K ^a   Levesque, Barrett G ^b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

irritable bowel syndrome; meta analysis; peppermint oil; treatment

Indexed keywords

MINTOIL; PEPPERMINT OIL; PLACEBO; UNCLASSIFIED DRUG; CHOLINERGIC RECEPTOR BLOCKING AGENT; MICROCAPSULE; VEGETABLE OIL;

ABDOMINAL PAIN; CROSSOVER PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; ENTERIC COATED TABLET; HEARTBURN; HUMAN; IRRITABLE COLON; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; TREATMENT DURATION; IRRITABLE BOWEL SYNDROME; MICROCAPSULE; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ABDOMINAL PAIN; CAPSULES; HUMANS; IRRITABLE BOWEL SYNDROME; PARASYMPATHOLYTICS; PLANT OILS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84902468429     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182a88357     Document Type: Review

References (40)

1. Hawthorn M, Ferrante J, Luchowski E, et al. The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Aliment Pharmacol Ther. 1988;2:101-118.
2. Hills JM, Aaronson PI. The mechanism and action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig. Gastroenterology. 1991;101:55-65.
3. Grigoleit HG, Grigoleit P. Gastrointestinal clinical pharmacology of peppermint oil. Phytomedicine. 2005;12:607-611.
4. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and meta-analysis. Am J Gastro-enterol. 1998;93:1131-1135.
5. Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008;337:a2313.
6. Weiss W, Koelbl CH. Treatment of irritable bowel syndrome with peppermint oil capsules: results of a double blind study. Therapiewoche Osterreich. 1988;3:3-8.
7. Schneider MME, Otten MH. Efficacy of Colpermin in the treatment of patients with irritable bowel syndrome. Gastro-enterology. 1990;98:A389.
8. Merat S, Khalili S, Mostajabi P, et al. The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome. Dig Dis Sci. 2010;55:1385-1390.
9. Alam MS, Roy PK, Miah AR, et al. Efficacy of peppermint oil in diarrhea predominant IBS-A double blind randomized placebo-controlled study. Mymensingh Med J. 2013;22: 27-30.
10. Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. Br Med J. 1978;2:653-654.
11. Drossman DA, Richter JE, Talley NJ. The Functional Gastrointestinal Disorders, Pathophysiology, and Treatment: a Multinational Consensus. 1st ed. Boston: Little Brown; 1994.
12. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut. 1999;45(suppl 2):II43-II47.
13. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. Available at: http//:www.cochrane-handbook.org.
14. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-926.
15. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) [Computer Program]. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2012.
16. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
17. Fernandez F. Peppermint in the treatment of irritable bowel syndrome. Invest Med Int. 1990;17:42-46.
18. Rees WD, Evans BK, Rhodes J. Treating the irritable bowel syndrome with peppermint oil. Br Med J. 1979;2:835-836.
19. Dew MJ, Evans BK, Rhodes J. Peppermint oil for the irritable bowel syndrome: a multicentre trial. Br J Clin Pract. 1984;38:394-398.
20. Nash P, Gould SR, Barnardo DE. Peppermint oil does not relieve the pain of irritable bowel syndrome. Br J Clin Pract. 1986;40:292-293.
21. Lawson MJ, Knight RE, Tran K, et al. Failure of enteric-coated peppermint in the irritable bowel syndrome: a randomized double-blind crossover study. J Gastroenterol Hepatol. 1988;3:235-238.
22. Ambross NS. Synthetic antispasmodic or peppermint for the irritable bowel syndrome sufferer?: A double blind comparative study. World Congress of Gastroenterology, Sydney, Australia, 1990: Abstract PP693.
23. Carling L, Svedberg LE, Hulton S. Short term treatment of the irritable bowel syndrome: a placebo-controlled trial of peppermint oil against hyoscyamine. Opusc Med. 1989;34:55-57.
24. Ahmad S, Butt WA, Mahmood S. Peppermint oil and irritable bowel syndrome. Pak J Gastroenterol. 1987;1:34-38.
25. Muenst GJ, Schlaurl H, Nuesch HJ, et al. Peppermint oil (Colpermin) compared to mebeverine (Duspatalin) in the therapy of irritable bowel syndrome. A double-blind study. Therapiewoche Schweiz. 1987;9:853-858.
26. Czalbert HJ, Neder M, Feher K. Experiences with colpermin therapy (Tillotts-England) in patients with irritable colon syndrome. Gyogyszereszet. 1990;34:251-253.
27. Shaw G, Srivastava ED, Sadlier M, et al. Stress management for irritable bowel syndrome: a controlled trial. Digestion. 1991;50:36-42.
28. Wildgrube HJ. The efficacy of peppermint oil on symptoms and functional parameters in patients with irritable bowel syndrome (study). Naturheilpraxis. 1988;41:591-596.
29. Evans BK, Levine DF, Mayberry JF, et al. Multicenter trial of peppermint oil capsules in irritable bowel syndrome. Scand J Gastroenterol. 1982;17:503.
30. Rhodes J, Evans BK, Rees WD. Peppermint oil in enteric coated capsules for the treatment of irritable bowel syndrome: a double blind controlled trial. Hepatogastroenterology. 1980; 27(suppl):E31.6.
31. Bell GD, Richmond CR, Somerville KW. Peppermint oil capusles (Colpermin) for the irritable bowel syndrome: a pharmacokinetic study. Br J Clin Pharmacol. 1983;16: 228p-229p.
32. Somerville KW, Richmond CR, Bell GD. Delayed release peppermint oil capsules (Colpermin) for the spastic colon syndrome: a pharmacokinetic study. Br J Clin Pharmacol. 1984;18:638-640.
33. Capanni M, Surrenti E, Biagini MR, et al. Efficacy of peppermint oil in the treatment of irritable bowel syndrome: a randomized controlled trial. Gazz Med Ital. 2005;164:119-126.
34. Cappello G, Spezzaferro M, Grossi L, et al. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Dig Liver Dis. 2007;39:530-536.
35. Lech AY, Olesen KM, Hey H, et al. Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo. Ugeskr Laeger. 1988;150:2388-2389.
36. Liu JH, Chen GH, Yeh HZ, et al. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol. 1997;32: 765-768.
37. Kline RM, Kline JJ, DiPalma J, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001;138: 125-128.
38. Lesbros-Pantoflickova D, Michetti P, Fried M, et al. Meta-analysis: the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20:1253-1269.
39. Poynard T, Naveau S, Mory B, et al. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 1994;8:499-510.
40. Kline KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology. 1988;95:232-241.